In a randomized controlled trial evaluating metformin for GDM, obesity was not associated with PE in metformin- and/or insulin-treated women, but the incidence of PE was significantly associated with being overweight. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.